Healthcare

Grifols (Biomat USA) Plasma Center | Chicago, IL

3718 N Central Ave Chicago, Illinois United States 60634
Asking Price
Area Size
NOI Net Operating Income
Cap Rate

Documents

Enter the "Deal room" for exclusive documents related to this property.

The Deal Room features confidential documents related to this property. To access the Deal Room, you will need to be logged in. If you don't have an account, please create one. More questions? Visit our FAQ.
I accept the confidentiality agreement
Create an account on the Investor Center to save your search and investment preferences, save and share opportunities, access exclusive documents, and more. More questions? Visit our FAQ. Approval for Deal Room access requires review by our Broker Team. You will be notified by email once your access is granted. More questions? Visit our FAQ. You'll need to sign a Confidentiality Agreement (CA) to access exclusive documents in the Deal Room. Signing the CA means you agree not to divulge or release sensitive information related to this property. More questions? Visit our FAQ.
I accept the confidentiality agreement I accept the confidentiality agreement
Create an account on the Investor Center to save your search and investment preferences, save and share opportunities, access exclusive documents, and more. More questions? Visit our FAQ. You'll need to sign a Confidentiality Agreement (CA) to access exclusive documents in the Deal Room. Signing the CA means you agree not to divulge or release sensitive information related to this property. More questions? Visit our FAQ.

Key facts

Year Built 1988
Building Area Gross
Land Area Gross ()
Rentable Area
Occupancy 100.0 %

Property description

JLL is pleased to offer for sale the fee simple interest in the Biomat USA Plasma Collection Center (the “Property”) located in the city of Chicago, Illinois. The Property is leased to Biomat USA (the “Tenant”), one of the world’s largest networks of plasma donation centers and wholly-owned subsidiary of multinational biotechnology manufacturer, Grifols, SA (S&P: BB; stable outlook). The Tenant is operating on a long-term net lease with ten years of primary lease term remaining, 10% rent escalations every five years, and minimal landlord responsibilities.

The Property is undergoing major renovations with over $3.8 million ($282 PSF) of capital investment to deliver in Q3 2022. Situated in Chicago’s Portage Park neighborhood eight miles northwest of Downtown Chicago and two blocks north of Community First Medical Center (299-bed hospital), this opportunity offers investors a premier medical office leased to an industry-leading healthcare operator in the heart of Chicago MSA.

Investment highlights

ESSENTIAL HEALTHCARE OPERATOR SUPPORTED BY ITS GLOBAL BIOTECH PARENT

  • Tenant operates one of the largest plasma collection networks of 296+ facilities throughout the U.S.
  • Grifols operates 370+ plasma collection facilities worldwide, doubling its footprint since 2016, and plans to expand over 40% to 520+ locations by 2026.
  • Grifols is proven to be recession-resistant, increasing revenues over 21% (4.9% CAGR) since 2017 to $5.9 billion in 2021.
  • Grifols’ leading division, Bioscience (77% of H1 2021 revenues), relies heavily on the availability of plasma supply, which is procured solely by donors of its collection center network. 


LEADING CHICAGO HEALTHCARE MARKET WITH OUTSTANDING DEMOGRAPHICS

  • Positioned in a medical node steps to Community First Medical Center (299-bed) with excellent access to 960,000 residents earning nearly $100,000 average household income (five-mile radius).
  • Third most populous U.S. metropolitan and largest Midwest healthcare market with $2.06 billion of medical capital expenditures in a five-mile radius.
  • Adjacent to Central Avenue offering seamless access and traffic counts of over 23,800 VPD.


OPTIMAL LONG-TERM NET LEASE WITH MINIMAL LANDLORD EXPENSES

  • Ten years of lease term, 10% rent escalations every five years, and minimal landlord responsibilities supported by new roof, HVAC, and parking lot upgrades.
  • Highly replicable contract rent coupled with extensive 2022 upgrades totaling $3.8 million ($2.0 million by Tenant), accentuates the Tenant’s strong desire for the location.
  • Three, 5-year renewal options, whose high likelihood of being exercised is enhanced by the Tenant’s significant interior build-out and aggressive expansion plans.
Last Updated Date: 11 Aug 2022

There was an error submitting your request. Please try again, or submit you inquiry here.

 

PRIVACY NOTICE

Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.

Generally the personal information we collect from you are for the purposes of dealing with your enquiry.

We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.

Last Updated Date: 11 Aug 2022

Do you have any questions?  Visit our FAQ page

JLL  financing

JLL can help you finance and manage your portfolio.
Email us today to see how we can help achieve your ambitions.